Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Gastroenterology. 2010 May 19;139(5):1538–1548. doi: 10.1053/j.gastro.2010.05.002

TABLE 1.

Fasting concentrations and incremental area-under-the curve (iAUC) data for serum insulin and lipoproteins Sf >400

Variable Treatments
LF Sensory
Exposure		 HF Sensory
Exposure
Insulin
Fasting value (mU/L) 5.8±0.6 6.3 ± 0.3
Sensory exposure iAUC (mmol/L*hr) 3 ± 1 7 ± 1 a
Post-capsule IAUC (mmol/L*hr) 13 ± 4 26 ± 8 a
Post-lunch iAUC (mmol/L*hr) 121 ± 11 140 ± 12 a
Total daylong iAUC (mmol/L*hr) 133 ± 12 166 ± 17 a
Sf >400-TAG
Fasting value (μmol/L) 23 ± 4 33 ± 7
Sensory exposure iAUC (μmol/L*hr) 17 ± 5 46 ± 15 a
Post-capsule IAUC (μmol/L*hr) 217 ± 70 272 ± 90
Post-lunch iAUC (μmol/L*hr) 1056 ± 173 1361 ± 268
Total daylong iAUC (μmol/L*hr) 1273 ± 221 1633 ± 342

Data are mean ± SEM (n=10). Data for iAUC are relative to the fasting value and the phases (sensory exposure, post-capsule, etc) are described in the methods section.

a

P < 0.02 LF sensory exposure compared to HF sensory exposure.